Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN plus AD) for Advanced Stage Classic Hodgkin Lymphoma: Updated Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part B)Hun Lee,Ian W. Flinn,Jason Melear,Rod Ramchandren,Judah Friedman,John M. Burke,Yuliya Linhares,Paul Alan Gonzales,Mihir Raval,Rangaswamy Chintapatla,Tatyana Feldman,Habte Yimer,Miguel Islas-Ohlmayer,Asad Dean,Vishal Rana,Mitul Gandhi,John Renshaw,Linda Ho,Michelle A. Fanale,Wenchuan Guo, Christopher A. YasenchakBlood(2022)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要